Document Detail


Cardiotoxin III induces apoptosis in K562 cells through a mitochondrial-mediated pathway.
MedLine Citation:
PMID:  16026508     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. Cardiotoxin (CTX) III is a basic polypeptide with 60 amino acid residues isolated from Naja naja atra venom. This is the first report on the mechanism of the anticancer effect of CTX III on human leukaemia K562 cells. 2. Cardiotoxin III was found to inhibit the growth of K562 cells in a time- and dose-dependent manner, with an IC(50) value of 1.7 mug/mL, and displayed several features of apoptosis, including apoptotic body formation, an increase in the sub-G(1) population, DNA fragmentation and poly (ADP-ribose) polymerase (PARP) cleavage. 3. Investigation of the mechanism of CTX III-induced apoptosis revealed that treatment of K562 cells with CTX III resulted in the loss of mitochondrial membrane potential, cytochrome c release from mitochondria into the cytosol and activation of caspase-9 and caspase-3 and the subsequent cleavage of the caspase-3 substrate PARP; however, CTX III did not generate reactive oxygen species (ROS). 4. Taken together, the results indicate that CTX III induces apoptosis in K562 cells through an ROS-independent mitochondrial dysfunction pathway.
Authors:
Sheng-Huei Yang; Ching-Ming Chien; Mei-Chin Lu; Yu-Jhang Lu; Zchong-Zcho Wu; Shinne-Ren Lin
Related Documents :
15806978 - Protection of hepatocytes from apoptosis by a novel substance from actinomycetes cultur...
16414118 - Enhanced cystatin c and lysosomal protease expression following 6-hydroxydopamine expos...
16308138 - Induction of apoptosis by the aqueous extract of rubus coreanum in ht-29 human colon ca...
15371238 - Time-dependent apoptosis of alveolar macrophages from rats exposed to bleomycin: involv...
16684508 - Epidermal-type fatty acid binding protein as a negative regulator of il-12 production i...
21195158 - Chrysin promotes tumor necrosis factor (tnf)-related apoptosis-inducing ligand (trail) ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical and experimental pharmacology & physiology     Volume:  32     ISSN:  0305-1870     ISO Abbreviation:  Clin. Exp. Pharmacol. Physiol.     Publication Date:  2005 Jul 
Date Detail:
Created Date:  2005-07-19     Completed Date:  2006-06-09     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0425076     Medline TA:  Clin Exp Pharmacol Physiol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  515-20     Citation Subset:  IM    
Affiliation:
Faculty of Medicinal and Applied Chemistry, Kaohsiung Medical University, Kaohsiung, Taiwan ROC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Apoptosis / drug effects*
Caspase 3
Caspase 9
Caspases / metabolism
Cell Survival / drug effects
Cobra
Cobra Cardiotoxin Proteins / chemistry,  pharmacology*
DNA Fragmentation / drug effects
Dose-Response Relationship, Drug
Flow Cytometry / methods
Humans
Hydrogen Peroxide / metabolism
Intracellular Fluid / drug effects,  metabolism
K562 Cells
Mitochondria / physiology*
Signal Transduction / drug effects,  physiology
Chemical
Reg. No./Substance:
0/Cobra Cardiotoxin Proteins; 0/cardiotoxin III, Naja naja atra; 7722-84-1/Hydrogen Peroxide; EC 3.4.22.-/CASP3 protein, human; EC 3.4.22.-/CASP9 protein, human; EC 3.4.22.-/Caspase 3; EC 3.4.22.-/Caspase 9; EC 3.4.22.-/Caspases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  New insights into beta-adrenoceptors in smooth muscle: distribution of receptor subtypes and molecul...
Next Document:  Antidiabetic effect of a new peptide from Squalus mitsukurii liver (S-8300) in alloxan-diabetes.